Literature DB >> 29480760

Malignant Mesothelioma and Its Non-Asbestos Causes.

Richard L Attanoos, Andrew Churg, Francoise Galateau-Salle, Allen R Gibbs, Victor L Roggli1.   

Abstract

CONTEXT: - Although many mesotheliomas are related to asbestos exposure, not all are, and there is increasing information on other causes of mesothelioma.
OBJECTIVE: - To provide a review of non-asbestos causes for malignant mesothelioma. DATA SOURCES: - Review of relevant published literature via PubMed and other search engines.
CONCLUSIONS: - Currently, most pleural mesotheliomas (70% to 90%) in men in Europe and North America are attributable to asbestos exposure; for peritoneal mesothelioma the proportion is lower. In North America few mesotheliomas in women at any site are attributable to asbestos exposure, but in Europe the proportion is higher and varies considerably by locale. In certain geographic locations other types of mineral fibers (erionite, fluoro-edenite, and probably balangeroite) can induce mesothelioma. Therapeutic radiation for other malignancies is a well-established cause of mesothelioma, with relative risks as high as 30. Carbon nanotubes can also induce mesotheliomas in animals but there are no human epidemiologic data that shed light on this issue. Chronic pleural inflammation may be a cause of mesothelioma but the data are scanty. Although SV40 can induce mesotheliomas in animals, in humans the epidemiologic data are against a causative role. A small number of mesotheliomas (probably in the order of 1%) are caused by germline mutations/deletions of BRCA1-associated protein-1 ( BAP1) in kindreds that also develop a variety of other cancers. All of these alternative etiologies account for a small proportion of tumors, and most mesotheliomas not clearly attributable to asbestos exposure are spontaneous (idiopathic).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29480760     DOI: 10.5858/arpa.2017-0365-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  31 in total

1.  Molecular characterization of diffuse malignant peritoneal mesothelioma.

Authors:  Yin P Hung; Fei Dong; Matthew Torre; Christopher P Crum; Raphael Bueno; Lucian R Chirieac
Journal:  Mod Pathol       Date:  2020-06-05       Impact factor: 7.842

2.  Workshop summary: Potential usefulness and feasibility of a US National Mesothelioma Registry.

Authors:  Kristin J Cummings; Michael J Becich; David J Blackley; Dennis Deapen; Robert Harrison; Raffit Hassan; S Jane Henley; Mary Hesdorffer; D Kevin Horton; Jacek M Mazurek; Harvey I Pass; Emanuela Taioli; Xiao-Cheng Wu; Marjorie G Zauderer; David N Weissman
Journal:  Am J Ind Med       Date:  2019-11-19       Impact factor: 2.214

Review 3.  Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.

Authors:  Michele Carbone; Prasad S Adusumilli; H Richard Alexander; Paul Baas; Fabrizio Bardelli; Angela Bononi; Raphael Bueno; Emanuela Felley-Bosco; Francoise Galateau-Salle; David Jablons; Aaron S Mansfield; Michael Minaai; Marc de Perrot; Patricia Pesavento; Valerie Rusch; David T Severson; Emanuela Taioli; Anne Tsao; Gavitt Woodard; Haining Yang; Marjorie G Zauderer; Harvey I Pass
Journal:  CA Cancer J Clin       Date:  2019-07-08       Impact factor: 508.702

4.  Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma.

Authors:  Jeronimo Rafael Rodríguez-Cid; Orlando García-Acevedo; Javier Benjamin-Contreras; Diana Bonilla-Molina; Rodrigo Rafael Flores-Mariñelarena; Luis Martínez-Barrera; Jorge Arturo Alatorre-Alexander; Carla Paola Sanchez-Ríos; Maria Del Rosario Flores-Soto; Patricio Javier Santillan-Doherty; Erika Sagrario Peña-Mirabal
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 5.  Peritoneal disease: key imaging findings that help in the differential diagnosis.

Authors:  Nuno M F Campos; Vânia Almeida; Luís Curvo Semedo
Journal:  Br J Radiol       Date:  2021-11-23       Impact factor: 3.039

6.  Establishment and characterization of a new malignant peritoneal mesothelioma cell line, KOG-1, from the ascitic fluid of a patient with pemetrexed chemotherapy resistance.

Authors:  Tomoko Akahane; Akira Hirasawa; Issei Imoto; Aki Okubo; Manabu Itoh; Yoshiko Nanki; Tomoko Yoshihama; Eichiro Tominaga; Daisuke Aoki
Journal:  Hum Cell       Date:  2019-10-03       Impact factor: 4.174

Review 7.  The Molecular Basis of Malignant Pleural Mesothelioma.

Authors:  Benjamin Wadowski; Assunta De Rienzo; Raphael Bueno
Journal:  Thorac Surg Clin       Date:  2020-09-12       Impact factor: 1.750

8.  Acute popliteal thrombus workup leads to discovery of primary peritoneal mesothelioma in the absence of any known asbestos exposure.

Authors:  Syed Tausif Ahmed; Matthew Barvo; Nayana Kamath; Richard Alweis
Journal:  BMJ Case Rep       Date:  2020-02-09

Review 9.  When the Diagnosis of Mesothelioma Challenges Textbooks and Guidelines.

Authors:  Giulio Rossi; Fabio Davoli; Venerino Poletti; Alberto Cavazza; Filippo Lococo
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

Review 10.  Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma.

Authors:  Benjamin Wadowski; Raphael Bueno; Assunta De Rienzo
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.